DNAJC5 and malaria: These data demonstrate that unique, structure-designed nanoparticles, administered without adjuvant, have the ability to induce both antibody and cellular responses in mice that, together or independently, are able to sterilely protect mice against sporozoites which display on their surface the CSP of the human malaria parasite P. falciparum.